IT8521130A0 - Aril-10 diidrossi-1,8 antroni eloro esteri, loro procedimento di preparazione ed il loro impiego in medicina umana oin medicina veterinaria e nel settore cosmetico. - Google Patents

Aril-10 diidrossi-1,8 antroni eloro esteri, loro procedimento di preparazione ed il loro impiego in medicina umana oin medicina veterinaria e nel settore cosmetico.

Info

Publication number
IT8521130A0
IT8521130A0 IT8521130A IT2113085A IT8521130A0 IT 8521130 A0 IT8521130 A0 IT 8521130A0 IT 8521130 A IT8521130 A IT 8521130A IT 2113085 A IT2113085 A IT 2113085A IT 8521130 A0 IT8521130 A0 IT 8521130A0
Authority
IT
Italy
Prior art keywords
medicine
anthrons
aril
dihydroxy
gold
Prior art date
Application number
IT8521130A
Other languages
English (en)
Other versions
IT1190365B (it
Inventor
Shroot Braham
Lang Gerard
Maignan Jean
Restle Serge
Original Assignee
Cird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird filed Critical Cird
Publication of IT8521130A0 publication Critical patent/IT8521130A0/it
Application granted granted Critical
Publication of IT1190365B publication Critical patent/IT1190365B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IT21130/85A 1984-06-13 1985-06-12 Aril-10 diidrossi-1,8 antroni e loro esteri,loro procedimento di preparazione ed il loro impiego in medicina umana oin medicina veterinaria e nel settore cosmetico IT1190365B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8409203A FR2565966B1 (fr) 1984-06-13 1984-06-13 Aryl-10 dihydroxy-1,8 anthrones et leurs esters, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique

Publications (2)

Publication Number Publication Date
IT8521130A0 true IT8521130A0 (it) 1985-06-12
IT1190365B IT1190365B (it) 1988-02-16

Family

ID=9304944

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21130/85A IT1190365B (it) 1984-06-13 1985-06-12 Aril-10 diidrossi-1,8 antroni e loro esteri,loro procedimento di preparazione ed il loro impiego in medicina umana oin medicina veterinaria e nel settore cosmetico

Country Status (11)

Country Link
JP (1) JPS6140238A (it)
BE (1) BE902642A (it)
CA (1) CA1253859A (it)
CH (1) CH664557A5 (it)
DE (1) DE3521074A1 (it)
DK (1) DK265185A (it)
FR (1) FR2565966B1 (it)
GB (1) GB2160864B (it)
IT (1) IT1190365B (it)
NL (1) NL8501699A (it)
SE (1) SE459807B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843097A (en) * 1984-06-13 1989-06-27 Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics
DE4231636A1 (de) * 1992-09-22 1994-03-24 Beiersdorf Ag Neue in 10-Stellung substituierte Anthron- und Anthracen-Derivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende pharmazeutische oder kosmetische Mittel und deren Verwendung
US5426197A (en) * 1993-07-19 1995-06-20 Teva Pharmaceutical Industries, Ltd. 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31289A (en) * 1968-01-08 1974-01-14 Ciba Geigy Ag Pharmaceutical preparation containing a dermatologically active difluorinated corticoid and dithranol
DE2154608A1 (de) * 1970-11-12 1972-06-29 Ciba-Geigy Ag, Basel (Schweiz) Neues Diacetat, pharmazeutische Präparate und Herstellungsverfahren
DE3002089A1 (de) * 1980-01-22 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue, substituierte 1,8-dihydroxy-9-(10h)-anthracenone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2492372A1 (fr) * 1980-10-21 1982-04-23 Cird Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2495934A1 (fr) * 1980-12-15 1982-06-18 Cird Composition pour le traitement du psoriasis a base d'une dihydroxy-1,8 anthrone-9 substituee en position 10

Also Published As

Publication number Publication date
GB2160864B (en) 1987-12-31
FR2565966B1 (fr) 1986-08-29
IT1190365B (it) 1988-02-16
BE902642A (fr) 1985-12-12
DK265185D0 (da) 1985-06-12
CA1253859A (fr) 1989-05-09
NL8501699A (nl) 1986-01-02
DE3521074A1 (de) 1985-12-19
JPS6140238A (ja) 1986-02-26
CH664557A5 (fr) 1988-03-15
GB2160864A (en) 1986-01-02
FR2565966A1 (fr) 1985-12-20
SE459807B (sv) 1989-08-07
SE8502910L (sv) 1985-12-14
GB8514973D0 (en) 1985-07-17
SE8502910D0 (sv) 1985-06-12
DK265185A (da) 1985-12-14

Similar Documents

Publication Publication Date Title
IT1176629B (it) Esteri di polioli, loro preparazione e loro impiego
IT1215379B (it) Composti benzopiranil e benzotiopiranil benzoici, loro procedimento di preparazione e loro impiego in cosmetica ed in medicina umana e veterinaria.
IT8722072A0 (it) Perossidi aromatici insaturi e loro impiego in terapia e in cosmetica.
IT8419308A0 (it) Procedimento per la preparazione di formulazioni galeniche particolarmente per uso farmaceutico, dietetico, cosmetico e diagnostico.
IT8719976A0 (it) Composti aromatici, loro procedimento di preparazione e loro impiego in medicina umana e veterinaria ed in cosmetica.
IT8124589A0 (it) Diidrossi-1,8 antroni-9 sostituiti in posizione 10 e loro impiego in medicina umana o in medicina veterinaria o in cosmetica.
IT8722408A0 (it) Derivati aromatici biciclici loro procedimento di preparazione e loro impiego in cosmetica e in medicina umana e vetenaria.
IT8468281A1 (it) Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
IT8720649A0 (it) Composti naftil aromatici, loro procedimento di preparazione e loro impiego in medicina umana e veterinaria e in cosmetica.
IT1189353B (it) Procedimento per la preparazione di insulina umana e suoi esteri
IT8521130A0 (it) Aril-10 diidrossi-1,8 antroni eloro esteri, loro procedimento di preparazione ed il loro impiego in medicina umana oin medicina veterinaria e nel settore cosmetico.
IT8521339A0 (it) Diacilossi-1,8 acil-10 antroni, loro procedimento di preparazione e loro impiego in medicina umana od in medicina veterinaria ed in cosmetica.
IT8620100A0 (it) Idrossi-1 acilossi-8 acil-10antroni, loro procedimento di preparazione e loro impiego in medicina umana o in medicina veterinaria e in cosmetica.
DK149545C (da) Stol omfattende saede, ryglaen og ben
IT8148166A0 (it) Ne e loro uso terapeutico esteri di mercaptoacil-carnitine procedimento per la loro preparazio
IT8622631A0 (it) Mono, di e tri-esteri del diidrossi 1,8 fenil 10 antrone 9 oppure antranolo-9 loro procedimento di preparazione e loro impiego in medicina umana o veterinaria e in cosmetica.
IT1139262B (it) Prodotti di addizione del diidrossi-1,8-antrone-9 e loro impiego in medicina umana o in medicina veterinaria ed in cosmetica
IT8619457A1 (it) Derivati insaturi cicloalifatici, loro procedimenti di preparazione e loro impiego in terapia e in cosmetica
DK299088D0 (da) Udvortes anvendeligt, antiviralt farmaceutisk praeparat akkumuleres i huden og fremgangsmaade til fremstilling deraf
IT8648189A0 (it) Benzammidi, loro procedimentodi preparazione e loro applicazione in campo terapeutico
GB2092588B (en) 1-8-dihydroxy-9-anthrones substituted in the 10-position by an unsaturated radical and their use in human and veterinary medicine and in cosmetics
IT7921794A0 (it) Esteri benzilidenici e loro impiego in terapeutica.
Strnad The transduction of inflammatory stimuli in human neutrophils
Picard The liability of doctors and hospitals in Canada
Emde Bacteria involved in the root rot disease complex of alfalfa